$5.470
-0.750 (-13.72%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de PRLD por análisis de gráficos similares
Alphio's PRLD stock price prediction model matches the current Prelude Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.44 (-0.62%). The 1-week path is $5.56 (+1.63%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Prelude Therapeutics Inc?
Prelude Therapeutics Inc is a good buy right now due to its current price of $5.47, which is significantly below analyst targets of $9 and $10, indicating potential upside. The company reported a 55% reduction in net loss for Q2, down to $13.92 million, and achieved $5.70 million in revenue, compared to no revenue in the same quarter last year. However, the main risk is the high volatility indicated by an implied volatility of 159.73% and a recent 5-day price change of -17.50%.
PRLD cerró en $5.47 el Friday, tras bajar -13.72%
Prelude Therapeutics Inc (PRLD) last closed at $5.47, losing -13.72%. These facts feed the 1-day and 1-week PRLD price prediction above.
Factores de la previsión
Los factores de la previsión de Prelude Therapeutics Inc (PRLD) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de PRLD, ordenadas por similitud.
Análisis de estacionalidad de PRLD
Historically the probability of a positive August return for PRLD is 71.43%. August offers the highest probability of a positive month at 71.43%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de PRLD
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $0.74 | $0.89 | $0.94 | -83.71% |
| Sep 2026 | $0.71 | $0.72 | $0.87 | -86.87% |
| Oct 2026 | $0.57 | $0.72 | $0.80 | -86.87% |
| Nov 2026 | $0.76 | $0.83 | $0.88 | -84.80% |
| Dec 2026 | $0.93 | $0.97 | $1.00 | -82.23% |
En 2026, se proyecta que Prelude Therapeutics Inc (PRLD) oscile entre $0.57 y $1.00.
Previsión mensual de Prelude Therapeutics Inc para 2026
En Aug de 2026, se proyecta que Prelude Therapeutics Inc promedie $0.89, con un mínimo de $0.74 y un máximo de $0.94.
En Sep de 2026, se proyecta que Prelude Therapeutics Inc promedie $0.72, con un mínimo de $0.71 y un máximo de $0.87.
En Oct de 2026, se proyecta que Prelude Therapeutics Inc promedie $0.72, con un mínimo de $0.57 y un máximo de $0.80.
En Nov de 2026, se proyecta que Prelude Therapeutics Inc promedie $0.83, con un mínimo de $0.76 y un máximo de $0.88.
En Dec de 2026, se proyecta que Prelude Therapeutics Inc promedie $0.97, con un mínimo de $0.93 y un máximo de $1.00.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.